Penile prosthesis in the management of erectile dysfunction following cancer therapy | Zendy

Pranav Dadhich | Zendy; Mark S. Hockenberry | Zendy; E. Will Kirby | Zendy; Larry I. Lipshultz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Penile prosthesis in the management of erectile dysfunction following cancer therapy

Author(s) -

Pranav Dadhich,

Mark S. Hockenberry,

E. Will Kirby,

Larry I. Lipshultz

Publication year - 2017

Publication title -

translational andrology and urology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.721

H-Index - 27

eISSN - 2223-4691

pISSN - 2223-4683

DOI - 10.21037/tau.2017.07.05

Subject(s) - erectile dysfunction , medicine , penile prosthesis , conservative management , intensive care medicine , cancer , population , prostate cancer , prosthesis , surgery , environmental health

Erectile dysfunction (ED) is a common problem in older men and occurs with even greater frequency following the treatment of pelvic malignancies. Inflatable penile prosthesis (IPP) implantation is a safe and effective form of definitive ED treatment for those men who fail more conservative measures, and it can be used with similar outcomes in men following cancer therapy. Although many of these men remain dissatisfied with other therapeutic options for ED, IPPs are underutilized in this population. This review will discuss the current practice patterns, outcomes and nuances to surgical technique regarding the use of IPPs in patients with ED following cancer therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research